Furthermore, YAP inhibition via verteporfin not only impaired the oncogenic properties of HR cells and sensitized these cells to trastuzumab but also mitigated cancer cell immune evasion by downregulating PD-L1 expression and inducing ICD. Here, CD274 is linked to cancer.